Try our Advanced Search for more refined results

December 06, 2023

Fust et al v. Gilead Sciences, Inc

Track this case

Case Number:

2:23-at-01244

Court:

California Eastern

Nature of Suit:

Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability

Multi Party Litigation:

Class Action

Firms

Companies

Sectors & Industries:

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. December 07, 2023

    Gilead Sued In Calif. Over Remdesivir COVID-19 Claims

    Patients hospitalized with COVID-19 and their surviving families are suing pharmaceutical company Gilead Sciences Inc. over the antiviral drug remdesivir, alleging the drug that received emergency approval in May 2020 was pushed through despite risks of organ damage and death, in a case removed to California federal court on Wednesday.

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login